Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS). (i-RISE)
i-RISE: International Acute Ischemic Stroke Study With the Penumbra System®
Sponsor: Penumbra Inc.
A observational or N/A phase clinical study on Acute Ischemic Stroke (AIS), this trial is actively recruiting participants. The trial is conducted by Penumbra Inc. and has accumulated 3 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Study Description(click to expand)Post-market, real-world, prospective, single-arm, multi-center study that will enroll up to 200 participants at up to 15 sites globally
Post-market, real-world, prospective, single-arm, multi-center study that will enroll up to 200 participants at up to 15 sites globally
Status Flow
Change History
3 versions recorded-
Apr 28, 2026 — Present [daily]
Recruiting
-
Jan 2026 — Apr 2026 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2025 — Jan 2026 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
The primary objective of this study is to collect real-world performance and safety data on the Penumbra System in a patient population with acute ischemic stroke (AIS)
Contact Information
- Penumbra Inc.
For direct contact, visit the study record on ClinicalTrials.gov .